DrugDashboards

Letrozole

Letrozole Tablets · LETROZOLE 2.5 mg/1 · Tablet, Film Coated · Oral · Yiling Pharmaceutical, Inc.

NDC 69117-0004-01 · 30 TABLET, FILM COATED in 1 BOTTLE · ANDA · View full market →

The short version

5 companies supply this market — a reasonable cushion if one runs into trouble. The price is down 16% over the past year, to $0.1203 per unit.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Part D plans paid (avg)$0.3359per dosage unitgross, before rebates — matched by drug name · 2024
  • Medicaid generic ceiling (FUL)$0.1880per TABweighted avg manufacturer price $0.1074 · Apr 1, 2023

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.1$0.2Feb 2020Aug 2023$0.1203
43 price points · per · last surveyed Invalid Date · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Medicaid spend (2025)

$148
11 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for letrozole (oral solid) in the next 90 days

price up 17% YoY · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
ANDA205869
TE code
AB
Approval date
Nov 14, 2018
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Letrozole Tablets (Tablet, Film Coated)

LabelerStrengthFirst seenLast seen
Avet Pharmaceuticals Inc.LETROZOLE 2.5 mg/1Jul 15, 2026Sep 2, 2026
Bryant Ranch PrepackLETROZOLE 2.5 mg/1Jul 15, 2026Sep 2, 2026
Golden State Medical Supply, Inc.LETROZOLE 2.5 mg/1Jul 15, 2026Sep 2, 2026
Upsher-Smith Laboratories, LLCLETROZOLE 2.5 mg/1Jul 15, 2026Sep 2, 2026
Yiling Pharmaceutical, Inc.LETROZOLE 2.5 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Letrozole — NDC 69117-0004-01," retrieved September 3, 2026, https://drugdashboards.com/drug/69117000401.

Free to cite with attribution — see how the data is put together.